1. Trudeau M, Gclmon K, Laing K, Latreille J, Mackey S, Mcleod D. Selection of adjuvant chemotherapy for treatment of node-negative breast cancer. Lancet Oncol. 2005;6:886–98.
2. Walter CW, Beverly R, Susan EH, David JH, Graham AC. Epidemiology and assessing and managing risk. In: Harris JR, Lippman ME, Osborne CK, editors. Diseases of the breast. 2nd ed. Philadelphia: Lippicott Williams and Wilkins; 2000. p. 175–95.
3. World Health Organization (WHO) Fact sheet N 297 February 2009; Available at: http://www.who.int/mediacentre/factsheets/fs297/en/index.html. 29 Jul 2010.
4. Seyednoori T, Zahmatkesh T, Malaie T, Akbari P, Haqi Z, Mohseniazad P. Assessment of breast cancer risk with Gill models. Iran J Breast Dis. 2008;1(2):53–7.
5. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med. 2001;344(4):276–85.